Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Aimwithimmunotherapy.org And The Various Resources The Site Provides For Patients And…
(WASHINGTON, March 12, 2019) — Yesterday, President Donald Trump released a fiscal year 2020 budget request that proposes a 12…
Wood LS, Hoffner B, Rubin K, Davies MJ, Tushla LA, Guild V, Guild SR. Background Immune checkpoint inhibitors (ICIs) have…
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Whats Next With Aimwithimmunotherapy.org. For More Info Visit: Aimwithimmunotherapy.org
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Benefits Of Aimwithimmunotherapy.org And The Various Resources It Provides For Patients…
Laura S. Wood, R.N., MSN, OCN, Cleveland Clinic Discusses Assessment & Education Regarding (irAEs). For More Info Visit: Aimwithimmunotherapy.org
Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted…
Dr. Jack West, Brendan Bietry, and Janet Freeman-Daily take questions from the audience about financial assistance, legal protections, and patient…
Dr. Eddie Garon considers the data on immunotherapies for first line treatment of advanced NSCLC and whether we are likely…
Dr. Julie Brahmer, Johns Hopkins University, discusses immunotherapies for NSCLC and SCLC, analyzes the relevant trial data and addresses the…
Dr. Ed Kim from the Levine Cancer Institute in Charlotte, NC summarizes the mechanism of next generation sequencing (NGS), how…
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific…
Dr. Ed Kim from the Levine Cancer Institute reviews the potential advantages and current limitations of blood-based testing for molecular…
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy options for treatment of both sensitive and refractory…
Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center reviews early trial data of immunotherapy agents for treatment of small…
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC defines the concept of cancer histology and gives…
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-01 With a focus on integrating recent advances into improved care pathways, this on-demand…
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-02 This on-demand webcast examines the efficacy and safety, indications, and cost utility of…
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-04 This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies…
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-03 This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality,…
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-05 This on-demand webcast examines recent clinical trial data for novel and emerging therapies,…
Edward B. Garon, M.D., MS Associate Clinical Professor, Director Of Thoracic Oncology Program, David Geffen School Of Medicine At UCLA,…
Edward B. Garon, M.D., MS Associate Clinical Professor, Director Of Thoracic Oncology Program, David Geffen School Of Medicine At UCLA,…
Robert Depriest, PharmD MBA Regional Sales Director At Walgreens, Discusses How To Participate In “Feel More Like You”. At MOASC…
Robert Depriest, PharmD MBA Regional Sales Director At Walgreens, Discusses Benefits Of “Feel More Like You” Program. At MOASC Oncology…
Robert Depriest, PharmD MBA Regional Sales Director At Walgreens, Discusses “Feel More Like You” Program. At MOASC Oncology Summit On…
Andrew Hendifar M.D. Medical Director, Pancreatic Cancer Assistant Professor, Medicine At Cedars-Sinai, Discusses Personalized Medicine In Pancreas Cancer. At MOASC…
Andrew Hendifar M.D. Medical Director, Pancreatic Cancer Assistant Professor, Medicine At Cedars-Sinai, Discusses Know Your Tumor Initiative. At MOASC Oncology…
Andrew Hendifar M.D. Medical Director, Pancreatic Cancer Assistant Professor, Medicine At Cedars-Sinai, Discusses Evolution Of Pancreatic Cancer Treatment. At MOASC…
Andrew Hendifar M.D. Medical Director, Pancreatic Cancer Assistant Professor, Medicine At Cedars-Sinai, Discusses Elaborating On Pancreas Cancer. At MOASC Oncology…
Gary Schiller, M.D. Professor of Medicine Division of Hematology/Oncology At UCLA, Discusses Whats New In AML Transplants. At MOASC Oncology…
Gary Schiller, M.D. Professor of Medicine Division of Hematology/Oncology At UCLA, Discusses Strategies To Treat AML. At MOASC Oncology Summit…
Gary Schiller, M.D. Professor of Medicine Division of Hematology/Oncology At UCLA, Discusses Elaborating On Drug Approvals In AML. At MOASC…
Gary Schiller, M.D. Professor of Medicine Division of Hematology/Oncology At UCLA, Discusses Approaches Seen In AML. At MOASC Oncology Summit…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses The…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses The…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses The…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses Mental…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses Medical…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses Insight…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses Details…
Edward B. Garon, M.D., MS Associate Clinical Professor, Director Of Thoracic Oncology Program, David Geffen School Of Medicine At UCLA,…
Andrew Hendifar, M.D. Medical Director, Pancreatic Cancer Cedars-Sinai Medical Center, Discusses Personalized Therapy For Pancreas Cancer: Have We Arrived? Dr.…
Amrita Krishnan, M.D. Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research Director, Multiple Myeloma Program Associate…
William Dale, M.D., PhD Professor & Arthur Coppola Family Chair, Department Of Supportive Care Medicine, City of Hope, Discusses Comprehensive…
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses Comprehensive Genomic Profiling Of Pancreatic Cancer. At The…
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses The Importance Of Genomic Profiling In Treating Colorectal…
John Strickler, M.D. Assistant Professor Of Medicine At Duke Cancer Institute, Discusses KEYNOTE-181 Esophageal Cancer Study. At The 2019 Gastrointestinal…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Embolization Therapy For Liver Cancer. At The 2019…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Data On Combining TKIs & Checkpoint Inhibitors In…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center, Discusses Checkpoint Inhibitors In The Treatment Of Liver Cancer.…
Ghassan Abou-Alfa, M.D. Attending Physician At Memorial Sloan Kettering Cancer Center Discusses, New Therapies In The Treatment Of Liver Cancer.…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Bassel El-Rayes, M.D. Professor & Vice Chair For Clinical Research, Department Of Hematology & Medical Oncology Emory University School Of…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses The Importance Of Precision Medicine…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Elderly Patients Benefit From Third…
Martine Extermann, M.D. Program Leader In The Senior Adult Oncology Program, Moffit Cancer Center, Discusses Thoughts On Third Line Study…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Correlation Between Modified Resist Criteria In HCC & Overall Survival…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses REFLECT Phase 3 Study Utilizing Lenvatinib & Recent Approval Of…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Thoughts On CCTG CO.26 Canadian Study Demonstrating Immunotherapy Benefit In…
Raymond Wadlow, M.D. Medical Oncologist At Inova Fairfax Hospital Discusses Data On KETNOTE-181 Esophageal Cancer Study Utilizing Pembrolizumab. At The…
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At…
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At…
Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses The…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Pembrolizumab,…
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC describes the use of serum tumor markers in…
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides evidence for the use of stereotactic body radiation…
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and…
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health…
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health…
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health…
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health…
Howard Hochster, MD, Associate Director for Clinical Research, Rutgers Cancer institute of New jersey, Director of Oncology Research, RWJBarnabas Health…
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Whether Regorafenib…
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Genetic Testing…
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Thoughts On…
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, Managing 2nd…
Jeffrey A. Meyerhardt, MD, Professor, Medicine, Harvard Medical School Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute discusses, BEACON Study…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, The Impact Of…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Sequencing TKIs In…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Thoughts On The…
Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, Stereotactic Body Radiation…
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann…
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann…
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann…
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann…
Philip Philip MD, PhD, FRCP, Professor of Oncology, Wayne State University School of Medicine, Clinical Professor of Oncology, Barbara Ann…
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses The Use Of Regorafenib In The Management Of Advanced…
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses Patient Selection & Treatment Algorithms In 2nd And 3rd…
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses The Role Of Circulating Tumor DNA (ctDNA). At The…
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses CCTG CO.26 Trial In Advanced Refractory CRC Presented At…
Axel Grothey, MD, Consultant, West Cancer Center, University of Tennessee, Discusses Next Generation Sequencing And mCRC. At The 2019 Gastrointestinal…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF,…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Pembrolizumab…
David Ilson, MD, PhD Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, Discusses Results…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Rachna Shroff, MD Chief, Section of GI Medical Oncology, Associate Professor of Medicine, Division of Hematology/Oncology, University of Arizona Cancer…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Andrew X. Zhu, MD, PhD Associate Professor, Department of Medicine, Harvard Medical School, Director, Liver Cancer Research, Medicine, Massachusetts General…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Kim, MD, Gastrointestinal Oncology Department, Moffitt Cancer Center, Assistant Professor of Oncology, University of South Florida College of Medicine,…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Richard Finn, MD Professor of Clinical Medicine, Department of Medicine, Division of Hematology/ Oncology, Geffen School of Medicine, UCLA discusses…
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the use of stereotactic radiosurgery and stereotactic radiation…
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the history and current use of stereotactic radiation…
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend…
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Protein Biomarkers, PD-L1, & Multifactorial. At the Seventeenth International Kidney Cancer…
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Is The Secreted Variant Of PD-L1 A Systemic Immunosuppressant. At the…
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Data Regarding A Splice Variant Of PD-L1. At the Seventeenth International…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Which Patient For Which Treatment.…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Over-Diagnosis & Over-Treatment Of Kidney…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses Increasing Awareness In Kidney Cancer.…
John Leppert, M.D., M.S. Associate Professor – Med Center Line, Urology At Stanford University Discusses How To Better Treat Kidney…
Abhishek Tripathi, M.D. Assistant Professor Of Medicine In The Section Of Hematology/Oncology At Oklahoma Stephenson Cancer Center Discusses Adenosine Pathway…
Steven Raman, M.D. Director of Prostate MR Imaging and Interventions and UCLA Prostate MR Imaging Research Group Discusses, MRPET &…
Lisa X. Lee, M.D. Hematology/Oncology Specialist At University of California, Irvine Discusses, More Trials & Drugs Coming In 2019. At…
Lisa X. Lee, M.D. Hematology/Oncology Specialist At University of California, Irvine Discusses, How MAIA & FORTE Trials Effect Clinicians. At…
Lisa X. Lee, M.D. Hematology/Oncology Specialist At University of California, Irvine Discusses, Highlights Of MAIA, FORTE & Tourmaline MM-3 Trials.…
Tsering Lama Tamang, M.D. Division of Hematology and Oncology, University of California, Irvine Discusses Data On The ALLIANCE Trial. At…
Tsering Lama Tamang, M.D. Division of Hematology and Oncology, University of California, Irvine Discusses ALLIANCE Trial & Low MRD. At…
Tsering Lama Tamang, M.D. Division of Hematology and Oncology, University of California, Irvine Discusses ALLIANCE Trial & Its Effect On…
Tianyi Tang, M.D. Hematology/Oncology Fellow At University of California, Irvine Discusses How The MAIA Trial Will Effect Clinicians . At…
Tianyi Tang, M.D. Hematology/Oncology Fellow At University of California, Irvine Discusses Highlights Of The MAIA Trial. At MOASC on Jan…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Elizabeth Brem, M.D. HS Clinical Assistant Professor at Chao Comprehensive Cancer Center Discusses Where We Are In Our Understanding Of…
Elizabeth Brem, M.D. HS Clinical Assistant Professor at Chao Comprehensive Cancer Center Discusses Whats Next In DLBCL. At MOASC on…
Elizabeth Brem, M.D. HS Clinical Assistant Professor at Chao Comprehensive Cancer Center Discusses Next Steps In R-CHOP Studies. At MOASC…
Elizabeth Brem, M.D. HS Clinical Assistant Professor at Chao Comprehensive Cancer Center Discusses Two Abstracts That Could Effect Clinicians. At…
Elizabeth Brem, M.D. HS Clinical Assistant Professor at Chao Comprehensive Cancer Center Discusses Four Abstracts Presented At MOASC. At MOASC…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Newer Agents Coming Out For…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Updates On Thrombotic Microangiopathies. At…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Atypical Hemolytic Uremic Syndrome. At…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Data On TITAN Study &…
Deepa Jeyakumar, M.D. Assistant Clinical Professor, Division of Hematology/Oncology At University of California Irvine Discusses Three New Drugs Approved For…
Deepa Jeyakumar, M.D. Assistant Clinical Professor, Division of Hematology/Oncology At University of California Irvine Discusses Dosing Regarding Venetoclax. At MOASC…
Deepa Jeyakumar, M.D. Assistant Clinical Professor, Division of Hematology/Oncology At University of California Irvine Discusses Can Glasdegib Be Used As…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate,…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses What To Achieve With The TRACERx…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses Results From TRACERx Renal Study. At…
Samra Turajlic, M.D. Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, Discusses The TRACERx Renal Study. At the…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Tumor Enucleation Debate. At the Seventeenth International Kidney Cancer Symposium…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Overview of Sessions From KCA Miami. At the Seventeenth International…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Tumor Enucleation. At the Seventeenth International Kidney Cancer Symposium on…
Brian Shuch, M.D. Associate Professor of Urology at UCLA Discusses, Benefits Of Tumor Enucleation. At the Seventeenth International Kidney Cancer…
Sumantra Kumar Pal, M.D. Assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney…
Sumantra Kumar Pal, M.D. Assistant professor in the Department of Medical Oncology & Therapeutics Research and co-director of the Kidney…
Rana Mckay, M.D. Medical Oncologist, Assistant Professor of Medicine at The University Of California San Diego, discusses VEGF Plus Radium…
Rana Mckay, M.D. Medical Oncologist, Assistant Professor of Medicine at The University Of California San Diego, discusses Treating Patients With…
Rana Mckay, M.D. Medical Oncologist, Assistant Professor of Medicine at The University Of California San Diego, discusses Study Involving VEGF-Targeted…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Upcoming Data Coming In 2019. At the Seventeenth International Kidney…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Profiling Tumor Microenvironment. At the Seventeenth International Kidney Cancer Symposium…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Next Gen Immune Activation In Kidney Cancer. At the Seventeenth…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Figuring Out Best Drug Combo For Kidney Cancer. At the…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Discussing Combining Drugs In Kidney Cancer. At the Seventeenth International…
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology…
Alexander Kutikov, M.D. Chief, Division of Urology and Urologic Oncology Professor At Fox Chase Cancer Center, Department of Surgical Oncology…
Charles Drake, M.D., PhD of Columbia University Medical Center, Discusses Making Immunotherapy Work Better For Kidney Cancer. At the Seventeenth…
Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, discusses Can A Rituximab Biosimilar Replace…
Peter Vorhees, MD, Director of Outreach and Clinical Operations, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, discusses…
Swaminathan P. Iyer, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, discusses…
Elizabeth Budde, MD, Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses CAR-T Therapy…
Edward Copelan, MD, Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, discusses Molecular Profiling Of Patients. At…
Tatyana Feldman, MD, Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses Exciting Studies From ASH 2018…
Tatyana Feldman, MD, Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses ECHELON-2 Study. At The 60th…
Sen Zhuang, MD, PhD, VP, Oncology Clinical Research, Janssen, discusses Research & Development Philosophy At Janssen. At The 60th ASH…
Sattva Neelapu, MD, Department of Lymphoma and Myeloma, Division of Cancer Medicines, MD Anderson Cancer Center, discusses Clinical Studies Examining…
Samer Khaled, MD, Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses MEDALIST Study. At…
Samer Khaled, MD, Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses Incorporating Venetoclax Into…
Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses Potential Side Effects From Venetoclax + Rituximab In…
Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses MRD As A Surrogate Marker In CLL. At…
Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, Discusses Clinical Data That Could Change…
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Molecular…
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Current…
Rafael Fonseca, MD, Hematologist, Mayo Clinic, discusses Frontline MM Treatment Patterns. At The 60th ASH Annual Meeting on Dec 1,…
Rafael Fonseca, MD, Hematologist, Mayo Clinic, discusses TOURMALINE-MM3 Study In MM. At The 60th ASH Annual Meeting on Dec 1,…
Nikhil Munshi, MD, Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Professor of Medicine,…
Nikhil Munshi, MD, Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Professor of Medicine,…
John Burke, MD, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Beat…
John Burke, MD, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Gilteritinib…
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses…
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Lymphoma Program, City of Hope,…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T Cell Lymphoma Program, City of Hope,…
Frederick Locke, MD, Program Co-Leader, Immunology Moffitt Cancer Center, discusses Improvements To Turn Around Time With CAR-T Therapies. At The…
Frederick Locke, MD, Program Co-Leader, Immunology Moffitt Cancer Center, discusses How To Integrate CAR-T With Stem Cell Transplant. At The…
Chadi Nabhan, MD, MBA, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses Skepticism Regarding MACRA. At The 60th ASH…
Chadi Nabhan, MD, MBA, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses Key Factors Contributing To Physician Burnout. At…
Carol Moreno, MD, PhD, Hematologist, University of Barcelona, discusses Outcomes Of The illUMINTATE Trial. At The 60th ASH Annual Meeting…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, Discusses The Role Of Checkpoint…
Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine, discusses Proteasome Inhibitors In The…
Elizabeth Budde, MD, Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses The Clinical…
Julie Vose, MD, Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Results Of The…
Julie Vose, MD, Professor, Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, Discusses Improvements Made In…
Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, discusses Outcomes Of The TOURMALINE-MM3 Study.…
Jasmine Zain, MD, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope,…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses The…
Tatyana Feldman, MD, Hematology & Oncology, Hackensack University Medical Center, John Theurer Cancer Center, discusses Improvements In The Treatment Of…
Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, discusses The Rationale For Genetically Profiling…
Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses Testing For Minimal Residual Disease In CLL. At…
Keith Pratz, MD, Assistant Professor of Oncology, Sidney Kimmel, Comprehensive Cancer Center, Johns Hopkins University, Discusses Phase I Study Of…
Keith Pratz, MD, Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, discusses Reliability Of The Companion…
Swaminathan P. Iyer, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, Discusses…
Andrzej Jakubowiak, MD, Professor of Medicine Director, Myeloma Program, University of Chicago Medical Center, discusses Thoughts On The POLLUX &…
Andrzej Jakubowiak, MD, Professor of Medicine Director, Myeloma Program, University of Chicago Medical Center, discusses ALCYONE Trial. At The 60th…
James McCloskey, MD, Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses Reliability Of The…
James McCloskey, MD, Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses Molecular Testing In…
David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses TOURMALINE-MM3 Study And The Treatment Of MM.…
David Siegel, MD, Hematologist/Oncologist, Hackensack University Medical Center, John Theurer Cancer Center, discusses Thoughts On The Daratumamab Studies. At The…
John Burke, MD, Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, discusses Incorporation…
Jeff Sharman, MD, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, Discusses…
Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of…
Lorenz Trumper, MD, Professor of Internal Medicine and Chairman of the Department of Hematology and Oncology, Georg August University of…
Maria-Victoria Mateos, MD, Associate Professor of Medicine, University of Salamanca, discusses TOURMALINE-MM3 Study. At The 60th ASH Annual Meeting on…
Ravi Vij, MD, Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine, discusses Anti-BCMA…
James McCloskey, MD, Interim Chief, Division of Leukemia, Hackensack University Medical Center, John Theurer Cancer Center, discusses How The FLT3…